Advertisement

Topics

Assessment of Primary Care Providers' Knowledge and Beliefs Regarding Gout Management

2014-08-27 03:12:37 | BioPortfolio

Summary

This is a questionnaire study aimed at learning about physicians' views on the treatment of Gout.

Description

We seek to assess the knowledge, beliefs and reported treatment practices of primary care physicians with regard to gout.

Specifically, we will:

- Assess the knowledge and beliefs with regard to acute and chronic gout management based on published treatment recommendations.

- Characterize the individuals who have knowledge deficits in terms of age, specialty, number of patients seen with gout, and practice setting.

- Assess the reported treatment practices of primary care physicians for the acute and chronic management of gout.

Study Design

Observational Model: Cohort, Time Perspective: Cross-Sectional

Conditions

Gout

Location

UMass Medical School
Worcester
Massachusetts
United States
01566

Status

Not yet recruiting

Source

University of Massachusetts, Worcester

Results (where available)

View Results

Links

Published on BioPortfolio: 2014-08-27T03:12:37-0400

Clinical Trials [88 Associated Clinical Trials listed on BioPortfolio]

Study of the Safety and Effectiveness of Rilonacept for the Prevention of Gout Flares

This is a clinical research study to determine the safety and effectiveness of an experimental drug called rilonacept in subjects with gout who are beginning another additional treatment. ...

PREventative Study Against URate-Lowering Drug-Induced Gout Exacerbations (PRE-SURGE 2)

The purpose of this clinical research study is to determine the safety and effectiveness of an experimental drug called rilonacept in subjects with gout who are beginning allopurinol treat...

PREventative Study Against URate-lowering Drug-induced Gout Exacerbations 1

The purpose of this clinical research study is to determine the safety and effectiveness of an experimental drug called rilonacept in subjects with gout who are beginning allopurinol treat...

Denosumab In Addition To Intense Urate-Lowering Therapy for Bone Erosions

Bone erosions are a common manifestation and feature of structural damage in severe/chronic tophaceous gout. Management of this destructive and often debilitating gout complication has foc...

Gout Self-Monitoring Aiming to Reach Target

This study evaluates whether a supported self-management approach to gout is able to achieve target levels of serum urate, and better control of gout flares.

PubMed Articles [97 Associated PubMed Articles listed on BioPortfolio]

Acute Gout in Emergency Admissions - Patient Characteristics and Adherence of Care Processes to Current Guidelines.

Gout or hyperuricemia are both well known and common diseases. The prevalence of gout is increasing worldwide. Thus, patients with gout are becoming more common. Although there are several published g...

4-(2-(4-chlorophenyl)-1-((4-chlorophenyl)amino)ethyl)benzene-1, 3-diol is a potential agent for gout therapy as a dual inhibitor of XOD and NLRP3.

Gout is an inflammatory arthritis characterized by abrupt self-limiting attacks of inflammation caused by precipitation of monosodium urate crystals (MSU) in the joint. Both anti-hyperuricemia and ant...

Any sleep is a dream far away: a nominal group study assessing how gout affects sleep.

There are no qualitative studies of sleep in gout; the aim of this study was to examine the impact of gout on sleep.

The History, Symptoms, Causes, Risk Factors, Types, Diagnosis, Treatments, and Prevention of Gout, Part 1.

Gout, a common and complex form of inflammatory arthritis, is characterized by abnormally elevated levels of uric acid in the blood. It is estimated that 52.5 million people in the U.S. have arthritis...

Treat to target in gout.

The treat-to-target (T2T) approach has been successfully implemented in a number of diseases. T2T has been proposed for rheumatic diseases such as RA, spondyloarthritis, lupus, and recently for gout. ...

Medical and Biotech [MESH] Definitions

Agents that increase uric acid excretion by the kidney (URICOSURIC AGENTS), decrease uric acid production (antihyperuricemics), or alleviate the pain and inflammation of acute attacks of gout.

Uricosuric that acts by increasing uric acid clearance. It is used in the treatment of gout.

An anti-inflammatory agent used in the treatment of rheumatoid arthritis. It also has uricosuric properties and has been used to treat gout.

A thiazole derivative and inhibitor of XANTHINE OXIDASE that is used for the treatment of HYPERURICEMIA in patients with chronic GOUT.

Gout suppressants that act directly on the renal tubule to increase the excretion of uric acid, thus reducing its concentrations in plasma.

More From BioPortfolio on "Assessment of Primary Care Providers' Knowledge and Beliefs Regarding Gout Management"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Gout
According to the National Arthritis Data Workgroup, an estimated 6 million people in the United States report having experienced gout at some point in their lives. In fact, gout is the most common form of inflammatory arthritis in men over the age of 40....

Rheumatology
Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...


Searches Linking to this Trial